CIBRA Capital »

Revance Therapeutics shares owned by CIBRA Capital

Quarter-by-quarter ownership of Revance Therapeutics shares owned by CIBRA Capital from 13F filings

Historical chart of CIBRA Capital investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by CIBRA Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by CIBRA Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.5M 1.1M 3.04